Cargando…
A Novel PET Imaging Using (64)Cu-Labeled Monoclonal Antibody against Mesothelin Commonly Expressed on Cancer Cells
Mesothelin (MSLN) is a 40-kDa cell differentiation-associated glycoprotein appearing with carcinogenesis and is highly expressed in many human cancers, including the majority of pancreatic adenocarcinomas, ovarian cancers, and mesotheliomas, while its expression in normal tissue is limited to mesoth...
Autores principales: | Kobayashi, Kazuko, Sasaki, Takanori, Takenaka, Fumiaki, Yakushiji, Hiromasa, Fujii, Yoshihiro, Kishi, Yoshiro, Kita, Shoichi, Shen, Lianhua, Kumon, Hiromi, Matsuura, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390102/ https://www.ncbi.nlm.nih.gov/pubmed/25883990 http://dx.doi.org/10.1155/2015/268172 |
Ejemplares similares
-
Novel single‐chain variant of antibody against mesothelin established by phage library
por: Yakushiji, Hiromasa, et al.
Publicado: (2019) -
A purification system for (64)Cu produced by a biomedical cyclotron for antibody PET imaging
por: Toyota, Teruaki, et al.
Publicado: (2012) -
Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer
por: Xu, Peng, et al.
Publicado: (2016) -
The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
por: Mizukami, Tatsuzo, et al.
Publicado: (2018) -
Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis
por: Shiraishi, Takehiro, et al.
Publicado: (2020)